Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000433244 | SCV000516287 | benign | not specified | 2015-10-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV001510692 | SCV001717790 | benign | Combined immunodeficiency due to ORAI1 deficiency; Myopathy, tubular aggregate, 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Unidad de Genómica Garrahan, |
RCV000433244 | SCV004233359 | benign | not specified | 2024-01-24 | criteria provided, single submitter | clinical testing | This variant is classified as Benign based on local population frequency. This variant was detected in 51% of patients studied by a panel of primary immunodeficiencies. Number of patients: 48. Only high quality variants are reported. |
Breakthrough Genomics, |
RCV001824758 | SCV005234439 | benign | not provided | criteria provided, single submitter | not provided | ||
Genome |
RCV001824758 | SCV002074721 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. |